₹ 161.86 Cr
2.34%
NIFTY Healthcare TRI
INF00XX01BM3
5000.0
1000.0
500
Dhimant Shah, Rohan Korde, Tanay Gabhawala
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option | 44.64 | - | - |
NIFTY Healthcare TRI | 49.8 | 13.64 | 20.09 |
Equity
Debt
Others
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 15.81 |
Max Healthcare Institute Ltd. | 6.15 |
Lupin Ltd. | 6.05 |
Dr. Reddy's Laboratories Ltd. | 5.37 |
Mankind Pharma Ltd. | 5.06 |
Apollo Hospitals Enterprise Ltd. | 4.75 |
Suven Pharmaceuticals Ltd. | 4.41 |
Divi's Laboratories Ltd. | 4.14 |
Zydus Lifesciences Ltd. | 3.62 |
Laurus Labs Ltd. | 2.93 |
Sector | Holdings (%) |
---|---|
Healthcare | 95.42 |
Chemicals | 4.25 |
Others | 0.33 |
Scheme Name | 5Y (%) |
---|---|
ITI Pharma and Healthcare Fund Reg IDCW | 0.0 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 23.56 |
SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
Nippon India Pharma Fund Gr Gr | 24.41 |
UTI Healthcare Reg Gr | 22.44 |
DSP Healthcare Reg Gr | 27.19 |
Mirae Asset Healthcare Reg Gr | 25.04 |
LIC MF Healthcare Fund Reg Gr | 19.52 |